Neurology Today in 5
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today, highlights the most noteworthy and newsworthy neurology stories from the current issue. Each episode provides a concise summary of key developments in neurology research and clinical practice. The podcast is produced by the American Academy of Neurology.
Episodes
Meat Intake and Cognitive Decline, Geographic Distribution of Research Funding, Artificial Intelligence's Role in Neurology
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a link between higher meat and slower cognitive decline in APOE34/44 carriers, the geographic distribution of research funding, and how artificial intelligence is reshaping neurology.
New Dopamine Agonist for Parkinson's, Artificial Intelligence in Medical Journals, Coffee and Dementia Risk
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a new selective dopamine agonist for people with Parkinson's disease, the use of artificial intelligence in preparing journal manuscripts, and caffeinated coffee's role in reducing dementia risk.
Neurology Match Day Growth, Diabetes and Dementia Risk, Public Health Discourse
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the increase in neurology residency matches this year, the risk of dementia in people with Type 1 diabetes, and the role of neurologists in the public health conversation.
Academic Jobs for Fellowship Graduates, Complex Neuromuscular Treatments, New Stroke Guideline
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the academic job market for fellowship graduates, the challenges of today's complex neuromuscular therapies, and the changes made in a new stroke guideline.
Acetaminophen Use During Pregnancy, Air Pollution and Motor Neuron Disease, Fremanezumab for Pediatric Migraine
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about acetaminophen use during pregnancy, the link between air pollution and motor neuron disease risk, and the use of fremanezumab for pediatric migraine.
ACGME neurocritical care accreditation, Jamaica hurricane aftermath, rituximab for multiple sclerosis
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about ACGME neurocritical care accreditation, how neurologists in Jamaica are recovering from hurricane damage, and the use of rituximab maintenance dosing in multiple sclerosis.
West Nile Neuroinvasive Disease, NINDS Director's Departure, Advanced Practice Provider Educational Funding
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about West Nile neuroinvasive disease, what's next after NINDS director Dr. Walter Koroshetz's departure, and changes to funding for advanced practice providers' education.
EMG Expertise, GLP-1s and Epilepsy, Astrocytoma Combination Therapy
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about EMG expertise, GLP-1s and epilepsy risk reduction, and combination therapy for recurrent IDH-mutant astrocytoma.
EMG Expertise, GLP-1s and Epilepsy, Astrocytoma Combination Therapy
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about EMG expertise, GLP-1s and epilepsy risk reduction, and combination therapy for recurrent IDH-mutant astrocytoma.
Lasmiditan Discontinuation, DAAN Designation, Alteplase for Eye Stroke
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the discontinuation of lasmiditan, the new DAAN designation, and the use of alteplase after eye stroke.
Genetic Counselors, Wrist-Worn Stimulation Device for Essential Tremor, CREST-2 Study Results
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the growing role of genetic counselors in neurology, a wrist-worn stimulation device for essential tremor, and results from the CREST-2 study of asymptomatic carotid disease.
Shunt Benefit in iNPH, Downstream Revenue, Anticoagulant Monotherapy
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the benefit of shunts in idiopathic normal-pressure hydrocephalus, how neurologists drive downstream revenue, and anticoagulant monotherapy after stroke.
P-tau217 Alzheimer's Blood Test, Tirofiban With Thrombolysis, Artificial Intelligence in Diagnostic Coding
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a p-tau217 blood test for Alzheimer's disease, the benefits of tirofiban with thrombolysis, and an AI tool that excels in diagnostic coding.
Medical school acceptance, hemorrhagic stroke surgery, brain tumors after TBI
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about medical school acceptance rates after the ending of affirmative action, minimally invasive surgery for hemorrhagic stroke, and the increased risk of brain tumors after traumatic brain injury.
Artificial sweeteners cognition concerns, drug company payments and prescribing decisions, graphene technology
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about artificial sweeteners' impact on cognitive health, how drug company payments influence prescribing decisions, and the use of graphene technology to accelerate maturation of neurons.
50 years of monoclonal antibodies, pregabalin and heart failure, combined therapy for primary progressive aphasia
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about how monoclonal antibodies revolutionized neurologic treatment, why pregabalin link to increased heart failure, and a combined therapy that slows progression in primary progressive aphasia.
Novel PET radiotracer, GLP-1s and dementia risk, green space benefits
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a PET radiotracer that shows intranasally delivered insulin enters the brain, GLP-1s and dementia risk in people with Type 2 diabetes, and how exposure to green space may reduce the risk of neurodevelopmental delays in children.
Pegivirus' role in Parkinson's disease, GLP-1s and idiopathic intracranial hypertension, geographic spread of epilepsy specialists
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about pegivirus's potential role in Parkinson's disease pathology, the impact of GLP-1 receptor agonistst on idiopathic intracranial hypertension, and the geographic spread of epilepsy specialists.
Food deserts and stroke risk, physical activity in Parkinson's disease, rimegepant for migraine
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the relationship between income, "food deserts," and stroke risk; why staying active may reduce cognitive decline in patients with Parkinson's disease; and how initiating rimegepant for migraine could help reduce opioid and butalbital use.
Parkinson's and dementia with Lewy bodies blood test, CAR T-cell therapy for glioblastoma, wireless EEG
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a promising blood test to distinguish Parkinson's disease from dementia with Lewy bodies, how CAR T-cell therapies are showing potential for patients with glioblastoma, and a new wireless electroencephalogram device that can even monitor young children with epilepsy.
Small fiber neuropathy, Dr. Merit Cudkowicz, work-life balance for families of neurologists
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about whether small fiber neuropathy is an autoimmune disorder; Merit Cudkowicz, MD, MSc, FAAN, recipient of this year's AAN Lifetime Achievement Award for Clinically Relevant Research; and how neurologist couples pursue work-life balance.
Divisive treatment for cluster headache, head positioning before thrombectomy, new series, "Neurology in America"
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about eptinezumab, a treatment for episodic cluster headache; how positioning the head flat before a thrombectomy benefited patients with large vessel occlusion stroke; and what rural neurology looks like in 2025, the first story in our new series, Neurology in America.
New treatment for giant-cell arteritis, links between oral and brain health, an emerging meningitis B vaccine
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about upadacitinib, a new treatment for giant-cell arteritis; growing evidence linking oral health to a higher risk of neurologic conditions; and why a trial of a new meningitis B vaccine drew a mixed response.
Telomere length and and risk for neurologic disorders, impact of research cuts on promotion/tenure, herpes zoster vaccine and dementia
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles on the association of shortened telomeres on risk for stroke, late-life depression and dementia; affect of research funding cuts on tenure/promotion opportunities; and herpes zoster vaccine and reduced dementia risk.
Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled.
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles studies showing persistent fatigue after TIA, the neurologic complications of measles, and the impact of the dismantling of a CDC surveillance program of epilepsy.
Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled.
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles studies showing persistent fatigue after TIA, the neurologic complications of measles, and the impact of the dismantling of a CDC surveillance program of epilepsy.
Advances in cell therapies for Parkinson's, GLP-1 agonists and dementia risk, FDA accelerated approvals for neurology drugs
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about early studies finding dopamine cellular therapies were safe and tolerable for patients with Parkinson's, use of GLP-1 agonists were associated with reduced dementia risks, and the FDA use of accelerated approvals for several neurology drugs are under scrutiny.
Microplastics in brain, salary gap in neurology, the neurology of space
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles finding microplastics in the brain postmortem linked to dementia, the salary gap between men and women neurologies, and neurologists studying the impact of microgravity on the brain.
Impact of high-dose Vitamin D on MS relapse, the role of AI in neurology education, and a 4D animal model that shows precursors of MS lesions before they appear.
In this episodeof Neurology Today in 5, Neurology Today editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a large trial that found high-dose Vitamin D reduced MRI evidence of disease activity in patients with clinically isolated syndrome or early relapsing MS; an animal brain map, revealing changes in inflammation, immune activity, and cell repair that preceded the appearance of MS lesions;
New approved drug for neurofibromatosis 1 with plexiform neurofibromas, multidisciplinary clinics in neurology, impact of cuts to DEI research grants
In this week's podcast, Neurology Today's editor-in-chief highlights articles on the newly approved drug for neurofibromatosis 1 with plexiform neuromas in adults, how neurology practices are integrating with multiple subspecialties, and the impact of federal cuts to DEI grants and research.
Impact of NIH cuts on neurology research, response to ACP's guideline on migraine, an updated position on seizures, driver licensure, and medical reporting
In this week's podcast, Neurology Today's editor-in-chief highlights articles on the impact of NIH cuts to indirect research costs, response to a new guideline on migraine prevention from ACP, and an updated position statement from the AAN on seizures, driver licensures, and medical reporting.
Lifetime burden of dementia, hidden features on EEGs for epilepsy detection, neurology-trained pharmacists
In this week's podcast, Neurology Today's editor-in-chief highlights articles on the larger lifetime burden of dementia than projected, an AI-fueled program that detects hidden features in EEGs for epilepsy detection, and neurology-trained pharmacists who are working with neurology departments.
IVF and MS relapse, community-based neurologists doing clinical research, and the loneliness protein implicated in brain function.
In this week's podcast, Neurology Today's editor-in-chief highlights articles on new data on IVF safety for women with MS, an elevated protein associated with loneliness, social isolation and brain function, and the role of community-based neurologists in drug development.
Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment
In this week's podcast, Neurology Today's editor-in-chief highlights articles on the pros and cons of virtual neurology education, the FDA approval of tirzepatide for obesity-related obstructive sleep apnea, and the promise of AI for glioma assessment.
Middle meningeal artery embolization and subdural hematoma, processed red meat and dementia risk, and editor picks for best neurology advances of 2024.
In this week's podcast, Neurology Today's editor-in-chief highlights articles on the safety of middle meningeal artery embolization for chronic subdural hematoma, the processed red meat and risk for dementia, and editors' picks for the best advances of 2024.
Magnesium sulfate for cerebral palsy, novel gene therapy for muscular dystrophies, chronic traumatic encephalitis and suicidality in retired NFL players.
In this week's podcast, Neurology Today's editor-in-chief highlights articles on the latest Cochrane review of magnesium sulfate to prevent cerebral palsy; a novel mRNA system for gene therapy for muscular dystrophies, and the perception of CTE and suicidality risk in retired NFL players.
Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty
In this week's podcast, Neurology Today's editor-in-chief highlights articles on proposed updated criteria for diagnosing MS before symptoms manifest, the use of large language models to address administrative burden with electronic medical records, and the growth of training programs in neonatal neurocritical care.
3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration
In this week's podcast, Neurology Today's editor-in-chief highlights articles on a study highlighting three-year outcomes for patients with anti-NMDAR encephalitis, an analysis comparing the diagnostic efficacy of skin biopsies vs. CSF tests for human prion diseases, and the ways in which a graduate degree in public health and/or business administration can shape career pathways for neurologists.
Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer's
In this week's podcast, Neurology Today's editor-in-chief highlights articles on the higher risk for cardiovascular effects with certain antiseizure therapies on adults with epilepsy, the impact of social determinants of health on children with MS, and the status of coverage for blood-based tests for Alzheimer's disease.
Fever prevention and stroke, environmental toxins and Parkinson's, cholesterol overload and ALS progression
In this week's podcast, Neurology Today's editor-in-chief highlights articles on fever prevention and stroke outcomes, the impact of air pollution and other environmental toxins on Parkinson's, and the role of cholesterol overload in ALS progression and disease risk.
Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder
In this week's podcast, Neurology Today's editor-in-chief highlights articles on the potential of a new blood biomarker for ALS, a PACP-targeted migraine therapy, and a real-world review of data on eculizumab for neuromyelitis optica spectrum disorder. This Podcast is being Sponsored by LocumTenens.com
Eastern equine encephalitis, systems for anti-amyloid therapies, new protocol for eye stroke
In this week's podcast, Neurology Today's editor-in-chief highlights articles on Eastern equine encephalitis relief, systems developed to meet demand for anti-amyloid therapies, and a new protocol for timely diagnosis and treatment for eye stroke in the emergency department. This Podcast is being Sponsored by LocumTenens.com
Brain circuit underlying placebo pain relief, common Parkinson's gene variants, blood biomarker testing for Alzheimer's
In this week's podcast, Neurology Today's editor-in-chief highlights new findings on brain pathways in placebo pain relief, that Parkinson's gene variants are more common than thought, and why there is momentum behind new blood biomarker tests for Alzheimer's.
Alzheimer's diagnosis criteria, AI and Parkinson's severity, neurotoxicity of racism
In this week's podcast, Neurology Today's editor-in-chief highlights a new workgroup's recommendations on biomarkers for diagnosing Alzheimer's, AI's ability to track Parkinson's severity from brief videos, and the latest research on how racism leads to neural changes and accelerated aging.
Weight loss drugs and optic neuropathy, normothermic regional perfusion, APPs in neurology practice
In this week's podcast, Neurology Today's editor-in-chief discusses data on the association between weight loss drugs and a rare type of optic neuropathy, ethical issues around normothermic regional perfusion, and how neurologists are onboarding and training advanced practice practitioners in comorbid cancer and stroke.
Body composition and neurologic disease, Tenecteplase and stroke related-disability, comorbid stroke and cancer
In this week's podcast, Neurology Today's editor-in-chief discusses data on the complex interaction between body composition, vascular health, and neurodegenerative disease, Tenecteplase in an extended treatment window and stroke-related disability, and gene expression in cormorbid cancer and stroke.
Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab
In this week's podcast, Neurology Today's editor-in-chief discusses data on an angiotensin receptor for blocker for hypertension associated with reduced risk for epilepsy, a study finding first responders to 9-11 clean-up sites had an increased risk for early dementia, and dementia experts comment on approval of donanemab.
Rescue therapies when endovascular thrombectomy fails, the impact of first-seizure clinics on outcomes, AI and sleep neurology
In this week's podcast, Neurology Today's editor-in-chief discusses data on the effectiveness of rescue therapies when endovascular thrombectomy fails, how first-seizure clinics reduce hospitalizations, and AI's use in sleep neurology.
When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs.
In this week's podcast, Neurology Today's editor-in-chief discusses a paper advising against prematurely withdrawing life support for severe TBI, data showing those with the highest composite score of inflammatory markers had a greater risk for stroke, original reporting stressing that residency programs and applicants need to adopt more strategic approaches to managing the overwhelming volume of
Code for ICH, new findings on Havana syndrome, distal symmetric polyneuropathy underdiagnosed in low income primary care clinics
In this week's podcast, Neurology Today's editor-in-chief discusses a push among neurocritical care experts to develop a code procedure for intracerebral hemorrhage, new findings showing people with Havana syndrome have functional neurologic disorder, and a study reporting distal symmetric polyneuropathy is more prevalent but less diagnosed in primary care clinics in low-income areas. This podc
Surgical removal of hematoma in ICH, disparities in neurodiagnosis for epilepsy, inequities among female neurology researchers
In this week's podcast, Neurology Today's editor-in-chief discusses a new study reporting better outcomes with surgical removal of hematoma in intracerebral hemorrhage, disparities in access to diagnosis and care for epilepsy, and the challenges that remain for women in neurology research.
Generative AI for personal statements, Match Day and neurology, AHS statement on CGRP-targeting therapies
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new articles that discuss program directors' response to the use of generative AI for personal statements, the good news for neurology based on the 2024 Match Day, and the AHS statement on CGRP-targeting therapies as a game changer for migraine treatment.
ME/CFS and long COVID; negative outcomes for ALS drug; donanemab
Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that explores an association between myalgic encephalomyelitis/chronic fatigue and long COVID; negative phase 3 findings on AMX0035 for ALS, and the pending approval of donanemab for Alzheimer's disease.
BTK inhibitors for MS, lecanemab, neurologic adverse effects and COVID vaccine
Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that casts doubt on the future of BTK inhibitors for MS, an assessment of the cost-effectiveness of lecanemab, and findings that COVID vaccines are not significantly associated with adverse neurologic events.
SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the impact of SARS-CoV2 on dopamine neurons, a European Medicines Agency warning about valproate risks for men, and neurologists on the pros and cons of working locum tenens.
AI and 911 stroke detection, iatrogenic Alzheimer's and human growth hormone, seizure dogs and refractory epilepsy
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the use of AI in EMS systems for stroke detection, the association between human growth hormone and iatrogenic Alzheimer's, and seizure dogs for refractory epilepsy.
Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a new study showing retinal vascular perfusion as a migraine biomarker, clinical and pathophysiological correlates of posterior cortical atrophy, and advances in gene therapies for neuromuscular disorders.
Cerebral amyloid angiopathy and nontraumatic subdural hemorrhage, AI for neurology boards, weight loss drugs and neurologic conditions
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing the cerebral amyloid angiopathy as a risk factor for nontraumatic subdural hemorrhage, AI beats humans in neurology-like boards, and the impact of popular weight loss drugs on neurologic conditions.
Rising incidence of Creutzfeldt-Jakob disease, therapy for prodromal migraine, neurotrauma of blast injury
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing the rising incidence of Creutzfeldt-Jakob disease, an effective therapy for prodromal migaine, and neuroinflammation in military personnel exposed to blast injury.
DBS and cognition in severe TBI, in utero exposure to antiseizure drugs, best advances of 2023
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on the impact of deep brain stimulation on cognition in severe traumatic brain injury and how adaptive functioning is impacted in children exposed to antiseizure drugs in utero, and the editorial board's picks for the best advances of 2023.
Parkinson's and suicide risk; biomarkers and underrepresentation in Alzheimer's trials, immune system changes in ALS and Parkinson's.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing double the suicide risk among Parkinson's patients; underrepresentation of non-White people in Alzheimer's trial related to biomarker eligibility; early immune systems changes may play early role in ALS and Parkinson's.
Serotonin and long COVID, Afib detected 3 years after stroke, Medicare on PET amyloid scans
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing serotonin depletion associated with long COVID; implantable cardiac monitors detect Afib 3 years post-stroke; and what Medicare's decision to cover PET amyloid scans means for neurologists.
A promising drug for refractory epilepsy; adverse childhood events and headache disorders; pathological engulfment by microglia in dementia.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on a promising potassium channel opener for refractory epilepsy; the impact of adverse childhood events in headache disorders; and excessive engulfment by microglia/astroctyes in dementia.
Blood transfusions and spontaneous intracerebral hemorrhages, long distance travel to neurologists, biomarkers for Parkinson's disease
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on the risk of spontaneous intracerebral hemorrhages after blood transfusions; the burden of long distance travel to see neurologists; and two promising biomarkers for early diagnosis of Parkinson's disease.
Blood pressure and endovascular therapy, cutbacks in neurology CME, blood test for Alzheimer's
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on blood pressure targets for stroke after endovascular therapy, changing policies on CME, and a direct-to-consumer blood test for Alzheimer's disease.
Football and Parkinson's, deep brain stimulation for stroke recovery, neuroprostheses for anarthric patients
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on football and the risk for Parkinson's disease, the potential of deep brain stimulation for recovery from stroke, and neuroprostheses for patients with anarthria.
Medicare coverage of carotid stenting, disparities in vulnerable neuro-oncology patients, optical EMG for neuromuscular disorders.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses the Medicare's proposed coverage of carotid stenting in asymptomatic patients,neuro-oncologists' perspectives on a federal initiative to target persistent poverty in vulnerable patients, and the technological promise of a new optical EMG for neuromuscular disorders.
Endovascular treatment and intracranial tumors; guideline on IVIG use for neuromuscular disorders, pros and cons of donanemab.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses research that assesses the safety of endovascular treatment post-stroke for people with intracranial tumors, the AANEM guideline on IVIG use for neuromuscular disorders, and the latest data on donanemab.
Oral health and cognitive decline; managing first-ever sleep seizures; growth of concierge neurology.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that associate poor oral health and risk for cognitive decline and how to manage first-ever sleep seizures that recur as well as the growth of concierge neurology.
Gene variants and MS severity, AI and EEG reads, neuroprotective agent for ischemic stroke
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that identify gene variants associated with MS severity/progression, an AI program that read EEGs accurately, and butylphthalide as a promising neuroprotective agent for ischemic stroke.
Antigen tolerance in mouse MS model, epileptiform activity and ICU outcomes, agent slows gliomas.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a novel therapeutic approach that induced antigen tolerance in an MS mouse model, the association between epileptiform activity and ICU outcomes, and an agent, vorasidenib, that slows low-grade gliomas.
Gout and risk of neurodegenereative diseases, Tenecteplase compared with warfarin, cognitive decline after heart attack
In this week's podcast, Neurology Today's editor-in-chief discusses the association between gout and neurodegenerative diseases, tenecrteplase vs.warfarin for acute stroke, expedited cognitive decline after a heart attack.
Antipsychotic for dementia-related agitation, contaminated water at Camp Lejeune associated with elevated risk for Parkinson's, gene variant confers resilience against autosomal dominant Alzheimer's.
In this week's podcast, Neurology Today's editor-in-chief discusses the FDA approval of an antipsychotic for agitation in dementia, elevated risk for Parkinson's in Camp Lejeune Marines exposed to contaminated water, a gene variant delays the onset of symptoms in man with autosomal dominant Alzheimer's. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
OnabotulinumtoxinA for pregnant women with migraine, adderrall shortage, AI for epilepsy
In this week's podcast, Neurology Today's editor-in-chief discusses a study on the safety of omnabotuliumtoxinA on pregnant women with migraine, the impact of the Adderall shortage on patients with ADHD and narcolepsy, and the state of AI for epilepsy. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com f
Assay detects Parkinson's before symptom onset; life stressors in pregnant women with epilepsy; role of inflammation in NORSE
In this week's podcast, Neurology Today's editor-in-chief discusses a new study reporting a gene assay detected Parkinson's before symptoms onset, life stressors greatly impact women with epilepsy during pregnancy; the role of inflammation in new-onset refractory status epilepticus. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
Anticoagulants for patients with dementia and Afib, tau levels in women taking hormone replace therapy, neurohumanities programs for neurology residents.
In this week's podcast, Neurology Today's editor-in-chief discusses a new study finding anticoagulants are safe for patients with atrial fibrillation and dementia, women on hormone replacement therapy had higher tau levels, and neurology residents are participants in humanities programs to foster wellness.
Fertility treatments for women with MS, stroke systems of care, ravalizumab for NMOSD
In this week's podcast, Neurology Today's editor-in-chief discusses a new study finding fertility treatments did not lead to MS relapses for women, a AHA consensus statement that finds stroke systems need improvement, and ravalizumab at less frequent doses was effective for neuromyelitis optica spectrum disorder.
Intranasal CGRP for migraine, ultrasound ablation for Parkinson's disease, novel therapeutic pathway for Duchenne muscular atrophy.
In this week's podcast, Neurology Today's editor-in-chief discusses the newly approved zavegepant for migraine, the potential/caveats of ultrasound ablation for Parkinson's disease, the transational potential of a new therapeutic target for Duchenne muscular atrophy.
Antipsychotics and dementia risk; biomarkers for lecanemab eligibility; trial of difelikefalin for neurogenic itch in notaliga paresthetica.
In this week's podcast, Neurology Today's editor-in-chief discusses the increased use of antipsychotics during the pandemic and an associated greater risk for dementia, determining the best biomarkers when considering lecanemab for Alzheimer's, and a novel approach for managing uncomfortable neuropathic symptoms.
Pregnancy-associated stroke outcomes; a robotic device for shoulder movement in ALS; non-invasive neurostimulation for refractory seizures.
In this week's podcast, Neurology Today's editor-in-chief discusses long-term adverse outcomes from pregnancy-associated stroke, a robotic device to assist shoulder movement in ALS, and the promise of neurostimulation for refractory seizures in the ICU.
Recommended
100% Mixtape Podcast
100 With The Hunter's
10-41: A UCSO Podcast
108.3 WGKSRADIO DEEP HOUSE PARTY
10 at a Time
10Fold Founders
10% Happier with Dan Harris
10-Minute Contrarian
10 Minutes Korean - Learn Korean & English Naturally
10 Minutes with Jesus
10 Minute Teacher Podcast with Cool Cat Teacher
10 minutos con Jesús
